Trial Profile
A Phase II/III Multicenter, Randomized, Double-Masked, Study of the Safety and Contraceptive Efficacy of C31G Compared to Conceptrol
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs C31G (Primary) ; Nonoxinol 9
- Indications Pregnancy
- Focus Therapeutic Use
- 07 Dec 2010 Results have been published in the December issue of Obstetrics and Gynecology v.116, according to an Adamis Pharmaceuticals media release.
- 31 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 Jun 2008 The expected completion date for this trial is now 1 Sep 2008 according to ClinicalTrials.gov.